Vytelle Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 106

Employees

  • Latest Deal Type
  • M&A

Vytelle General Information

Description

Operator of a biotechnology platform intended to assist in advancing bovine, deer, and buffalo genetics by redefining reproduction. The company's integrated platform leverages reproductive technology through industry specialists and veterinarian licensees to develop embryos using a proprietary culture system with no fetal calf serum, resulting in freezable embryos, enabling commercial producers to get generations of genetic gains that are sustainable for animals.

Contact Information

Website
www.vytelle.com
Formerly Known As
Cogent IVF, Cogent Holdings, Vytelle Holdings
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 8789 Penrose Lan
  • Suite 250
  • Lenexa, KS 66219
  • United States
+1 (866)
Corporate Office
  • 8789 Penrose Lan
  • Suite 250
  • Lenexa, KS 66219
  • United States
+1 (866)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vytelle Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 26-May-2026 Completed Generating Revenue
2. Later Stage VC (Series B) 03-Apr-2023 Completed Generating Revenue
1. Later Stage VC (Series A) 21-Sep-2021 $15.3M $15.3M Completed Generating Revenue
To view Vytelle’s complete valuation and funding history, request access »

Vytelle Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Vytelle’s complete cap table history, request access »

Vytelle Patents

Vytelle Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024308993-A1 Genotyping of cell-free dna from embryo culture media Pending 27-Jun-2023
US-20250029679-A1 Genotyping of cell-free dna from embryo culture media Pending 27-Jun-2023
WO-2025006702-A1 Genotyping of cell-free dna from embryo culture media Inactive 27-Jun-2023
AU-2024253144-A1 Microbiome treatments for animal fertility Pending 04-Apr-2023
US-20240366690-A1 Microbiome treatments for animal fertility Pending 04-Apr-2023 A61K35/74
To view Vytelle’s complete patent history, request access »

Vytelle Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vytelle Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ag-tech VC Venture Capital Minority
Forage Capital Partners PE/Buyout Minority
Fulcrum Global Capital Venture Capital Minority
Grosvenor Food & AgTech Impact Investing Minority
KCRise Fund Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Vytelle Acquisitions (1)

Vytelle’s most recent deal was a Merger/Acquisition with GrowSafe Systems. The deal was made on 13-Aug-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
GrowSafe Systems 13-Aug-2020 Merger/Acquisition Electronic Equipment and Instruments
To view Vytelle’s complete acquisitions history, request access »

Vytelle FAQs

  • When was Vytelle founded?

    Vytelle was founded in 2015.

  • Where is Vytelle headquartered?

    Vytelle is headquartered in Lenexa, KS.

  • What is the size of Vytelle?

    Vytelle has 106 total employees.

  • What industry is Vytelle in?

    Vytelle’s primary industry is Other Agriculture.

  • Is Vytelle a private or public company?

    Vytelle is a Private company.

  • What is Vytelle’s current revenue?

    The current revenue for Vytelle is .

  • How much funding has Vytelle raised over time?

    Vytelle has raised $35.3M.

  • Who are Vytelle’s investors?

    Ag-tech VC, Forage Capital Partners, Fulcrum Global Capital, Grosvenor Food & AgTech, and KCRise Fund are 5 of 9 investors who have invested in Vytelle.

  • When was Vytelle acquired?

    Vytelle was acquired on 26-May-2026.

  • Who acquired Vytelle?

    Vytelle was acquired by Trans Ova Genetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process